Obesity, Appetite Control & Diabetes

Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
- A1019 Glucagon (19-29), humanSummary: Potent Ca2+/Mg2+-ATPase inhibitor
- A1025 a-MSH, amideSummary: Melanocyte-stimulating hormones
- A1013 Endomorphin-1Summary: Agonist of μopioid receptors,highly potent and selective
- A1024 LEP (116-130) (mouse)Summary: An antiobesity hormone
- A1121 Melanocyte stimulating hormone release inhibiting factorSummary: MSH release-inhibiting factor
- A1115 Peptide YY(3-36), PYY, humanTarget: NPY ReceptorsSummary: Y2R agonist
- A1134 Agouti-related Protein (AGRP) (25-82), humanTarget: Melanocortin (MC) ReceptorsSummary: Agouti-related peptide(25-82)